Lympho Bob

A blog about Cancer in general, and Follicular Lymphoma in particular

Tuesday, April 12, 2022

Zevalin: Real-World Success for Follicular Lymphoma

›
First, a quick colonoscopy update: I had a biopsy during the procedure, and it came back benign. Right after the procedure, the doc said eve...
1 comment:
Thursday, April 7, 2022

Colonoscopy

›
I had a colonoscopy this morning. Everything looks pretty good. I'll hear about biopsy results in a week or so, but the doctor isn't...
1 comment:
Tuesday, April 5, 2022

How Patients Make The Treatment Decisions

›
The British medical journal BMJ Open has an interesting article this month called " Treatment Decision Making (TDM): A Qualitative Stud...
4 comments:
Thursday, March 31, 2022

Bi-Specific Antibodies for Refractory Lymphoma

›
Just a short post today. I've been very busy for the last few weeks, and that will keep up for a few more days, but I wanted to post som...
Sunday, March 27, 2022

Good News (for the EU) and Bad News (for PI3K Inhibitors)

›
I know I (sort of) promised to stop giving bad news about PI3K Inhibitors, but I can't help it if they keep giving me things to talk abo...
Monday, March 21, 2022

POD24 in Follicular Lymphoma

›
Important research from the journal Blood .  In the article called " Validation of POD24 as a Robust Early Clinical End Point of Poor S...
1 comment:
Tuesday, March 15, 2022

Biosimilars for Follicular Lymphoma

›
The journal JAMA Oncology recently published a review of 31 biosimilars for different cancers, including Follicular Lymphoma . The results ...
‹
›
Home
View web version

Contributors

  • Lymphomaniac
  • Lymphomaniac
Powered by Blogger.